News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Oxurion entre en négociations exclusives en vue d'acquérir les activités et les actifs d'Eclevar, une CRO spécialisée dans les MedTech
Oxurion NV entre en négociations exclusives pour acquérir Eclevar, une CRO française spécialisée en dispositifs médicaux, renforçant ainsi sa position dans le marché des CRO MedTech -
COMMUNIQUÉ DE PRESSE
Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
Oxurion NV (Euronext Brussels: OXUR) to acquire French CRO Eclevar, expanding into MedTech CRO market. Transaction details and growth potential outlined. Exclusive negotiations aim to close by 31 December 2026 -
COMMUNIQUÉ DE PRESSE
Matador Secondary Private Equity AG: Ad hoc announcement pursuant to Art. 53 LR SIX as to Art. 16 listing rules BX Swisss_Semiannual Report 2026
Matador Secondary Private Equity AG releases its Semiannual Report for the first half of 2026, reporting a profit of 5.04 million CHF. The company specializes in secondary private equity investments -
-
![Logo de [UNKNOWN]](https://logos.symex.be/img/.jpg)
